Journal of Gastrointestinal Oncology

Papers
(The TQCC of Journal of Gastrointestinal Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management84
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma70
The inhibitory effects of probiotics on colon cancer cells: in vitro and in vivo studies37
Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression35
Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA331
Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC)27
Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma25
Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer24
Toripalimab combined with docetaxel and cisplatin neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a single-center, single-arm clinical trial (ESONICT-2)22
Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 720
PD-L1 immunohistochemistry comparison of 22C3 and 28-8 assays for gastric cancer19
Omics analyses in peritoneal metastasis—utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review18
Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis18
Colorectal cancer surgery in elderly patients 80 years and older: a comparison with younger age groups17
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases—a systematic review17
Favorable tumor biology in locally advanced pancreatic cancer—beyond CA19-917
Esophageal cancer: the rise of adenocarcinoma over squamous cell carcinoma in the Asian belt17
Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in elderly patients with gastric cancer after surgery16
Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis16
Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK16
Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model15
The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review15
Value of nutrition support therapy in patients with gastrointestinal malignancies: a narrative review and health economic analysis of impact on clinical outcomes in the United States15
Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens15
Conversion surgery in patients with pancreatic cancer and peritoneal metastasis15
Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma15
miR-133a-5p suppresses gastric cancer through TCF4 down-regulation14
Machine learning-based random forest predicts anastomotic leakage after anterior resection for rectal cancer14
Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients14
Implications of the growing incidence of global colorectal cancer14
Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects14
Efficacy and tolerability of the combination of nano-liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma: post-approval clinic experience14
The diagnosis and outcome of Krukenberg tumors14
Immune checkpoint inhibitors in liver transplant: a case series14
High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma13
CD276 suppresses CAR-T cell function by promoting tumor cell glycolysis in esophageal squamous cell carcinoma13
Clinicopathological and prognostic significance of programmed death ligant-1 expression in gastric cancer: a meta-analysis13
Prognostic value and association of sarcopenic obesity and systemic inflammatory indexes in patients with hepatocellular carcinoma following hepatectomy and the establishment of novel predictive nomog13
Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience13
Value of multiphase contrast-enhanced CT with three-dimensional reconstruction in detecting depth of infiltration, lymph node metastasis, and extramural vascular invasion of gastric cancer13
Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 variant carriers13
Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology12
Morphine promotes angiogenesis by activating PI3K/Akt/HIF-1α pathway and upregulating VEGF in hepatocellular carcinoma12
UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation12
CXCL5/CXCL8 is a promising potential prognostic and tumor microenvironment-related cluster in hepatocellular carcinoma12
Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review12
Incidence and detection of high microsatellite instability in colorectal cancer in a Chinese population: a meta-analysis12
A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer12
Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway12
Crocin reverses 1-methyl-3-nitroso-1-nitroguanidine (MNNG)-induced malignant transformation in GES-1 cells through the Nrf2/Hippo signaling pathway11
Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer11
Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients11
Abrogation of ARF6 in promoting erastin-induced ferroptosis and mitigating capecitabine resistance in gastric cancer cells11
Pathology reporting of margin status in locally advanced pancreatic cancer: challenges and uncertainties11
Short and long-term outcomes after proximal gastrectomy with double tract reconstruction for Siewert type III adenocarcinoma of the esophagogastric junction: a propensity score matching study from a 111
The brain–gut axis in gastrointestinal cancers11
Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis11
Effectiveness of telerehabilitation on short-term quality of life of patients after esophageal cancer surgery during COVID-19: a single-center, randomized, controlled study11
Stereotactic body radiation therapy versus radiofrequency ablation for single small hepatocellular carcinoma: a propensity-score matching analysis of their impact on liver function and clinical outcom11
Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus11
Clinical efficacy and safety of 3D vascular reconstruction combined with 3D navigation in laparoscopic hepatectomy: systematic review and meta-analysis11
Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms11
CircBACH1/let-7a-5p axis enhances the proliferation and metastasis of colorectal cancer by upregulating CREB5 expression11
Extent of venous resection during pancreatectomy—finding the balance of technical possibility and feasibility10
Social determinants of health associated with poor outcome for rural patients following resected pancreatic cancer10
Molecular characterization of squamous cell carcinoma of the anal canal10
Short-term outcomes of laparoscopic versus open total gastrectomy after neoadjuvant chemotherapy: a cohort study using the propensity score matching method10
Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection10
Diagnostic genes and immune infiltration analysis of colorectal cancer determined by LASSO and SVM machine learning methods: a bioinformatics analysis10
Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study10
Bee venom protects against pancreatic cancer via inducing cell cycle arrest and apoptosis with suppression of cell migration10
Candidate oncogene circularNOP10 mediates gastric cancer progression by regulating miR-204/SIRT1 pathway10
The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure10
Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma10
Qingjie Fuzheng Granules regulates cancer cell proliferation, apoptosis and tumor angiogenesis in colorectal cancer xenograft mice via Sonic Hedgehog pathway10
Utility of feeding jejunostomy in patients with esophageal cancer undergoing esophagectomy with a high risk of anastomotic leakage10
Mitofusin-2 is a novel anti-angiogenic factor in pancreatic cancer10
New insights in the pathology of peritoneal surface malignancy10
Impact of perioperative intravenous lidocaine infusion on postoperative pain and rapid recovery of patients undergoing gastrointestinal tumor surgery: a randomized, double-blind trial10
Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis10
Correlation between Claudin-18 expression and clinicopathological features and prognosis in patients with gastric cancer10
Resectable, borderline, and locally advanced pancreatic cancer—“the good, the bad, and the ugly” candidates for surgery?10
Global trends in pancreas cancer among Asia-Pacific population10
The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma10
miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC)10
Correlation analysis of tumor mutation burden of hepatocellular carcinoma based on data mining9
A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients9
Prognostic significance of systemic immune-inflammation index- based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation9
Intra-operative hyperthermic intraperitoneal chemotherapy for prevention and treatment of peritoneal metastases from gastric cancer: a narrative review9
A narrative review of postoperative bleeding in patients with gastric cancer treated with endoscopic submucosal dissection9
Correlation of ulcerative colitis and colorectal cancer: a systematic review and meta-analysis9
Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol and recommended future directions9
A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin9
Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma9
Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancer9
Prognostic performance of different lymph node classification systems in young gastric cancer9
Review of management and treatment of peritoneal metastases from gastric cancer origin9
A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses9
Prognosis model of colorectal cancer patients based on NOTCH3, KMT2C, and CREBBP mutations9
c-MYC and HIF1α promoter G-quadruplexes dependent metabolic regulation mechanism of berberine in colon cancer9
Genome variation in colorectal cancer patient with liver metastasis measured by whole-exome sequencing9
Propofol activates AMPK to inhibit the growth of HepG2 cells in vitro and hepatocarcinogenesis in xenograft mouse tumor models by inducing autophagy9
LncRNA-CASC7 inhibits the proliferation and migration of colon cancer by negatively regulating the PI3K/Akt signaling pathway9
Colorectal cancer in pregnancy: a case report and literature review8
Construction of a co-expression network and prediction of metastasis markers in colorectal cancer patients with liver metastasis8
Hsa_circ_NOTCH3 regulates ZNF146 through sponge adsorption of miR-875-5p to promote tumorigenesis of hepatocellular carcinoma8
Expression characteristics of long non-coding RNA in colon adenocarcinoma and its potential value for judging the survival and prognosis of patients: bioinformatics analysis based on The Cancer Genome8
Combination of preoperative red cell distribution width and neutrophil to lymphocyte ratio as a prognostic marker for gastric cancer patients8
The assessment of intraoperative technique-related risk factors and the treatment of anastomotic leakage after esophagectomy: a narrative review8
Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes8
A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer8
PADI1 contributes to EMT in PAAD by activating the ERK1/2-p38 signaling pathway8
Neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib and S-1 chemotherapy for conversion therapy in gastric cancer patients with positive exfoliative cytology: a prospective stud8
Inhibition of ITGB1-DT expression delays the growth and migration of stomach adenocarcinoma and improves the prognosis of cancer patients using the bioinformatics and cell model analysis8
Identification and validation of xenobiotic metabolism-associated prognostic signature based on five genes to evaluate immune microenvironment in colon cancer8
Long non-coding RNA small nucleolar RNA host gene 7 facilitates the proliferation, migration, and invasion of esophageal cancer cells by regulating microRNA-6258
Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining8
N-myc downstream-regulated gene 2 promotes the protein stability of estrogen receptor beta via inhibition of ubiquitin-protein ligase E3A to suppress colorectal cancer8
Effects of molecular markers on the treatment decision and prognosis of colorectal cancer: a narrative review8
A narrative review of systemic treatment options for hepatocellular carcinoma: state of the art review8
LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling8
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma8
Clinical application of nano-carbon to improve the accuracy of lymph node staging in patients with advanced gastric cancer receiving neoadjuvant chemotherapy: a prospective randomized controlled trial8
The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis8
Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway8
Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database7
High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cance7
Predictive value of prognostic nutritional index on infection after radical gastrectomy: a retrospective study7
Yes-activated protein promotes primary resistance of BRAF V600E mutant metastatic colorectal cancer cells to mitogen-activated protein kinase pathway inhibitors7
Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma7
Pancreatic INI1-deficient undifferentiated rhabdoid carcinoma achieves complete clinical response on gemcitabine and nab-paclitaxel following immediate progression on FOLFIRINOX: a case report7
Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy7
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis7
Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database7
Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clin7
Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study7
Incidence and risk factors for sustained hepatic function toxicity 6 months after radioembolization: analysis of the radiation-emitting sir-spheres in non-resectable liver tumor (RESIN) registry7
Downregulation of Ascl2 promotes cell apoptosis by enhancing autophagy in colorectal cancer cells7
High expression of the TEFM gene predicts poor prognosis in hepatocellular carcinoma7
N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes7
Expression and prognostic significance of thrombospondin gene family in gastric cancer7
Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study7
Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection7
Serum calcium improved systemic inflammation marker for predicting survival outcome in rectal cancer7
Pathobiology, irradiation dosimetric parameters and therapy of radiation-induced gastric damage: a narrative review7
Current management of gastric adenocarcinoma: a narrative review7
Efficacy and safety of camrelizumab in combination with trastuzumab and chemotherapy as the first-line treatment for patients with HER2-positive advanced gastric cancer7
Bioinformatical identification of key genes regulated by IGF2BP2- mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma7
Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer7
Digestive tract reconstruction of laparoscopic total gastrectomy for gastric cancer: a comparison of the intracorporeal overlap, intracorporeal hand-sewn anastomosis, and extracorporeal anastomosis7
Outcomes of colorectal cancer surgery in nonagenarian patients: a multicenter retrospective study7
The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds7
LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB7
Combination of the ratio between metastatic and harvested lymph nodes and negative lymph node count as a prognostic indicator in advanced gastric cancer: a retrospective cohort study7
Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer7
A discussion of the gut microbiome’s development, determinants, and dysbiosis in cancers of the esophagus and stomach7
Combining the systemic inflammation response index and prognostic nutritional index to predict the prognosis of locally advanced elderly esophageal squamous cell carcinoma patients undergoing definiti7
Identification of a glycolysis-related gene signature for predicting pancreatic cancer survival7
Resveratrol inhibits the proliferation, invasion, and migration, and induces the apoptosis of human gastric cancer cells through the MALAT1/miR-383-5p/DDIT4 signaling pathway6
Correlation between L3 skeletal muscle index and prognosis of patients with stage IV gastric cancer6
The early predictive effect of low expression of the ITGA4 in colorectal cancer6
Cost-effectiveness of camrelizumab versus chemotherapy for the treatment of advanced or metastatic esophageal squamous cell carcinoma6
Advanced lung cancer inflammation index predicts the outcomes of patients with non-metastatic gastric cancer after radical surgical resection6
Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients6
Tripartite motif 52 (TRIM52) promotes proliferation, migration, and regulation of colon cancer cells associated with the NF-κB signaling pathway6
Liquid biopsies for colorectal cancer: a narrative review of ongoing clinical trials and the current use of this technology at a comprehensive cancer center6
Comprehensive analysis of the prognostic value of the chemokine-like factor-like MARVEL transmembrane domain-containing family in gastric cancer6
Relationship between plasma cell-free DNA (cfDNA) and prognosis of TACE for primary hepatocellular carcinoma6
Current state of prognostication, therapy and prospective innovations for Barrett’s-related esophageal adenocarcinoma: a literature review6
ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma6
Dynamics of neutrophil-to-lymphocyte ratio predict outcomes of metastatic colorectal carcinoma patients treated by FOLFOX6
A HER2-mutant patient with late-stage duodenal adenocarcinoma benefited from anti-HER2 therapy and PD-1 inhibition: a case report6
Proton stereotactic body radiation therapy for liver metastases—results of 5-year experience for 81 hepatic lesions6
The effect of different inferior mesenteric artery ligation levels and different lymph node dissection areas on the short- and long-term outcomes of rectal cancer6
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies6
Disparities and survival in newly diagnosed gastric cancer in Hispanic patients in the United States: a propensity score matched analysis6
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survival6
Construction and assessment of a joint prediction model and nomogram for colorectal cancer6
MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM36
Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/ DUSP6/ERK axis6
Amplification of the human epidermal growth factor receptor 2 (HER2) gene is associated with a microsatellite stable status in Chinese gastric cancer patients6
Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study6
Comprehensive bioinformatics analysis of functional molecules in colorectal cancer6
Prognostic prediction and gene regulation network of EIF2S2 in hepatocellular carcinoma based on data mining6
Addition of transarterial chemoembolization improves outcome of tyrosine kinase and immune checkpoint inhibitors regime in patients with unresectable hepatocellular carcinoma6
A narrative review of intraperitoneal chemotherapy and cytoreductive surgery (CRS) for peritoneal metastases in gastric cancer6
XPA serves as an autophagy and apoptosis inducer by suppressing hepatocellular carcinoma in a PI3K/Akt/mTOR dependent manner6
The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma6
Preoperative nomogram to predict survival following colorectal cancer liver metastasis simultaneous resection6
Can local ablative techniques replace surgery for locally advanced pancreatic cancer?6
Perioperative versus total neoadjuvant chemotherapy in gastric cancer6
Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo6
LncRNA NORAD mediates KMT2D expression by targeting miR-204-5p and affects the growth of gastric cancer6
Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer6
MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance6
miRNA-320 inhibits colitis-associated colorectal cancer by regulating the IL-6R/STAT3 pathway in mice6
Development of a model to predict pathologic response to chemotherapy in patients with colorectal liver metastases6
STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway6
Diabetes mellitus and postoperative blood glucose value help predict posthepatectomy liver failure in patients with hepatocellular carcinoma6
A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis6
Clinical significance and correlation of miR-200c and P-gp expression in gastric cancer and the effects on multidrug resistance6
FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC6
Serum biomarkers predict adjuvant chemotherapy-associated symptom clusters in radical resected colorectal cancer patients6
The stress hyperglycemia ratio, a novel index of relative hyperglycemia, predicts short-term mortality in critically ill patients after esophagectomy6
Comprehensive analysis of the relationship between competitive endogenous RNA (ceRNA) networks and tumor infiltrating-cells in hepatocellular carcinoma6
Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer6
Chemosensitivity of gastric cancer: analysis of key pathogenic transcription factors5
Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-415
Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients5
Diagnostic and prognostic potential of the novel biomarker nuclear cap binding protein subunit 2 (NCBP2) in colon adenocarcinoma5
The clinical features, management, and survival of elderly patients with colorectal cancer5
Depletion of insulin-like growth factor 1 receptor increases radiosensitivity in colorectal cancer5
A systematic review and meta-analysis on the efficacy of Compound Kushen Injection in 3 kinds of digestive tract tumor5
Chemoprotective effect of boeravinone B against 1,2-dimethyl hydrazine induced colorectal cancer in rats via suppression of oxidative stress and inflammatory reaction5
Survival and prognostic factors for postoperative primary appendiceal cancer: a retrospective cohort study based on the Surveillance, Epidemiology, and End Results database5
Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis5
Increased RBM12 expression predicts poor prognosis in hepatocellular carcinoma based on bioinformatics5
IL-1 receptor-associated kinase 1 participates in the modulation of the NLRP3 inflammasome by tumor-associated macrophages in hepatocellular carcinoma5
Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma5
Trichostatin A enhances radiosensitivity and radiation-induced DNA damage of esophageal cancer cells5
The deficiency of FKBP-5 inhibited hepatocellular progression by increasing the infiltration of distinct immune cells and inhibiting obesity-associated gut microbial metabolite5
Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review5
Serum N-glycan profiling as a diagnostic biomarker for the identification of hepatitis B virus-associated hepatocellular carcinoma5
ATG16L2 overexpression is associated with a good prognosis in colorectal cancer5
Lymph node metastasis risk factors and applicability of endoscopic submucosal dissection in mixed-type early gastric cancer in Chinese patients5
CircRHOT1 restricts gastric cancer cell ferroptosis by epigenetically regulating GPX45
Perineural invasion is a prognostic factor in stage II colorectal cancer but not a treatment indicator for traditional chemotherapy: a retrospective cohort study5
Development and validation of an XGBoost model to predict 5-year survival in elderly patients with intrahepatic cholangiocarcinoma after surgery: a SEER-based study5
Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels5
Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma5
Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma5
Prediction of early recurrence of hepatocellular carcinoma after resection based on Gd-EOB-DTPA enhanced magnetic resonance imaging: a preliminary study5
Narrative review of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian cancer: a critical reappraisal of the current evidence5
Obstructive sleep apnea and the incidence and mortality of gastrointestinal cancers: a systematic review and meta-analysis of 5,120,837 participants5
High expression of MAGE-C1 gene in colorectal cancer is associated with its poor prognosis5
NCAPG is transcriptionally regulated by CBX3 and activates the Wnt/β-catenin signaling pathway to promote proliferation and the cell cycle and inhibit apoptosis in colorectal cancer5
Oxaliplatin-based hyperthermic intraperitoneal chemotherapy with single drug versus multiple drug treatment for colorectal cancer with peritoneal metastases: an observational cohort study5
Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma5
miR-375 suppresses the growth and metastasis of esophageal squamous cell carcinoma by targeting PRDX15
Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research5
Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection5
Transjugular intrahepatic portosystemic shunt for the management of symptomatic malignant pseudocirrhosis5
Outcome of surgical treatment for bone metastases caused by colorectal cancer5
REXO4 acts as a biomarker and promotes hepatocellular carcinoma progression5
Gastric cancer complicated with hemophagocytic lymphohistiocytosis: case report and a brief review5
Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score match5
Glypican 1 promotes proliferation and migration in esophagogastric adenocarcinoma via activating AKT/GSK/β-catenin pathway5
Effect of the systemic immune-inflammation index on postoperative complications and the long-term prognosis of patients with colorectal cancer: a retrospective cohort study5
Prediction and prognostic significance of ALOX12B and PACSIN1 expression in gastric cancer by genome-wide RNA expression and methylation analysis5
Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma5
0.10110092163086